Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS.

Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12.

PMID:
17569110
2.

Biomarkers for prediction of cardiovascular events.

Ridker PM, Cook NR.

N Engl J Med. 2007 Apr 5;356(14):1472-3; author reply 1474-5. No abstract available.

PMID:
17415901
3.

Biomarkers for prediction of cardiovascular events.

Musunuru K, Blumenthal RS.

N Engl J Med. 2007 Apr 5;356(14):1472; author reply 1474-5. No abstract available.

4.
5.

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

Ridker PM, Buring JE, Rifai N, Cook NR.

JAMA. 2007 Feb 14;297(6):611-9. Erratum in: JAMA. 2007 Apr 4;297(13):1433.

PMID:
17299196
6.

Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study.

Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG.

Eur Heart J. 2007 Feb;28(3):354-62. Epub 2007 Jan 9.

PMID:
17213229
7.

Multiple biomarkers for the prediction of first major cardiovascular events and death.

Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS.

N Engl J Med. 2006 Dec 21;355(25):2631-9.

8.

C-reactive protein and cardiovascular disease risk: still an unknown quantity?

Davey Smith G, Timpson N, Lawlor DA.

Ann Intern Med. 2006 Jul 4;145(1):70-2. No abstract available.

PMID:
16818931
9.

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

Cook NR, Buring JE, Ridker PM.

Ann Intern Med. 2006 Jul 4;145(1):21-9.

PMID:
16818925
10.

Biomarkers of cardiovascular disease: molecular basis and practical considerations.

Vasan RS.

Circulation. 2006 May 16;113(19):2335-62. Review. No abstract available.

11.

The efficacy of combining several risk factors as a screening test.

Wald NJ, Morris JK, Rish S.

J Med Screen. 2005;12(4):197-201.

PMID:
16417697
12.

C-reactive protein comes of age.

Verma S, Szmitko PE, Ridker PM.

Nat Clin Pract Cardiovasc Med. 2005 Jan;2(1):29-36; quiz 58. Review.

PMID:
16265340
14.

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute.

Circulation. 2005 Oct 25;112(17):2735-52. Epub 2005 Sep 12. Review. No abstract available. Erratum in: Circulation. 2005 Oct 25;112(17):e298. Circulation. 2005 Oct 25;112(17):e297.

15.

Genetic variation in alcohol dehydrogenase 1C and the beneficial effect of alcohol intake on coronary heart disease risk in the Second Northwick Park Heart Study.

Younis J, Cooper JA, Miller GJ, Humphries SE, Talmud PJ.

Atherosclerosis. 2005 Jun;180(2):225-32. Epub 2005 Jan 15.

PMID:
15910847
16.

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group.

Fortmann SP, Ford E, Criqui MH, Folsom AR, Harris TB, Hong Y, Pearson TA, Siscovick D, Vinicor F, Wilson PF; CDC; AHA.

Circulation. 2004 Dec 21;110(25):e554-9.

17.

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.

Smith SC Jr, Anderson JL, Cannon RO 3rd, Fadl YY, Koenig W, Libby P, Lipshultz SE, Mensah GA, Ridker PM, Rosenson R; CDC; AHA.

Circulation. 2004 Dec 21;110(25):e550-3. No abstract available.

18.

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group.

Myers GL, Rifai N, Tracy RP, Roberts WL, Alexander RW, Biasucci LM, Catravas JD, Cole TG, Cooper GR, Khan BV, Kimberly MM, Stein EA, Taubert KA, Warnick GR, Waymack PP; CDC; AHA.

Circulation. 2004 Dec 21;110(25):e545-9. No abstract available.

19.
20.

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P.

Am J Epidemiol. 2004 May 1;159(9):882-90. Review.

PMID:
15105181

Supplemental Content

Support Center